跳至主要内容
临床试验/EUCTR2015-005146-55-BE
EUCTR2015-005146-55-BE进行中(未招募)1 期

The effect of methylphenidate (Ritalin®) on the severity of stuttering. - The effect of methylphenidate (Ritalin®) on the severity of stuttering.

Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel0 个研究点目标入组 30 人开始时间: 2015年12月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Developmental stuttering
  • 18 years or older
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Psychological disorders: depression, psychosis, bipolar disorder.
  • Psychogenic of neurogenic stuttering
  • Narcolepsy.
  • Use of methylphenidate (now or in the past).
  • AHT (blood pressure above 140/90).
  • Use of benzodiazepines, neuroleptics such as haloperidol, amphetamines, anti- emetics such as metoclopramide and domperidone, L-dopa, MAO inhibitors.
  • Stroke or TIA.
  • Hyperthyroidism.
  • Cocaine or other drug use (now or in the past).
  • Drug addiction (now or in the past).
  • Alcoholism.
  • Known liver disease.

研究者

发起方
Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel

相似试验